{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:59:45Z","timestamp":1792040385050,"version":"4.4.0"},"reference-count":184,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013072","name":"Major Science and Technology Project of Hainan Province","doi-asserted-by":"publisher","award":["221100310200"],"award-info":[{"award-number":["221100310200"]}],"id":[{"id":"10.13039\/501100013072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.mtbio.2024.101126","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T15:58:43Z","timestamp":1718294323000},"page":"101126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3383-541X","authenticated-orcid":false,"given":"Rongyue","family":"Xue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8544-2384","authenticated-orcid":false,"given":"Hao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongheng","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.mtbio.2024.101126_bib1","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/17425247.2014.935338","article-title":"Advances in ocular drug delivery: emphasis on the posterior segment","volume":"11","author":"Kang-Mieler","year":"2014","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.mtbio.2024.101126_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108115","article-title":"Biological functions of tear film","volume":"197","author":"Pflugfelder","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mtbio.2024.101126_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2018.06.031","article-title":"Polymer-based carriers for ophthalmic drug delivery","volume":"285","author":"Imperiale","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101126_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jconrel.2021.04.008","article-title":"Challenges and strategies for the delivery of biologics to the cornea","volume":"333","author":"Wels","year":"2021","journal-title":"J. Contr. Release"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010028","article-title":"Ocular drug delivery barriers-role of nanocarriers in the treatment of anterior segment ocular diseases","volume":"10","author":"Bachu","year":"2018","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1007508714259","article-title":"Role of P-glycoprotein in restricting propranolol transport in cultured rabbit conjunctival epithelial cell layers","volume":"17","author":"Yang","year":"2000","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib7","first-page":"465","article-title":"The emerging role of topical ocular drugs to target the posterior eye, OPHTHALMOL","volume":"10","author":"Wang","year":"2021","journal-title":"THER"},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000108117","article-title":"Transport barriers in transscleral drug delivery for retinal diseases","volume":"39","author":"Kim","year":"2007","journal-title":"Ophthalmic Res."},{"issue":"8","key":"10.1016\/j.mtbio.2024.101126_bib9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/jop.2013.0063","article-title":"Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model","volume":"29","author":"Abarca","year":"2013","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"9","key":"10.1016\/j.mtbio.2024.101126_bib10","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/acs.molpharmaceut.9b00585","article-title":"Distribution of small molecular weight drugs into the porcine lens: studies on imaging mass spectrometry, partition coefficients, and implications in ocular pharmacokinetics","volume":"16","author":"Heikkinen","year":"2019","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib11","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/j.1600-0420.2007.00885.x","article-title":"Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye","volume":"85","author":"Sigurdsson","year":"2007","journal-title":"Acta Ophthalmol. Scand."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11095-008-9745-6","article-title":"Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina","volume":"26","author":"Kim","year":"2009","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10010010","article-title":"Ophthalmic drug delivery systems for antibiotherapy-A review","volume":"10","author":"Dubald","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib14","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101126_bib15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.visres.2017.05.009","article-title":"The inner blood-retinal barrier: cellular basis and development","volume":"139","author":"Diaz-Coranguez","year":"2017","journal-title":"Vis. Res."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib16","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/jop.2020.0022","article-title":"Mucus-penetrating particles and the role of ocular mucus as a barrier to micro- and nanosuspensions","volume":"36","author":"Popov","year":"2020","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib17","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/1389200215666140926152459","article-title":"Role of membrane transporters and metabolizing enzymes in ocular drug delivery","volume":"15","author":"Vadlapatla","year":"2014","journal-title":"Curr. Drug Metabol."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exer.2005.10.029","article-title":"P-Glycoprotein expression in human retinal pigment epithelium cell lines","volume":"83","author":"Constable","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mtbio.2024.101126_bib19","first-page":"422","article-title":"P-glycoprotein expression in human retinal pigment epithelium","volume":"8","author":"Kennedy","year":"2002","journal-title":"Mol. Vis."},{"issue":"19","key":"10.1016\/j.mtbio.2024.101126_bib20","doi-asserted-by":"crossref","first-page":"19781","DOI":"10.1074\/jbc.M310785200","article-title":"Characterization of oligomeric human half-ABC transporter ATP-binding cassette G2","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mtbio.2024.101126_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.addr.2017.12.008","article-title":"Implications of melanin binding in ocular drug delivery","volume":"126","author":"Rimpela","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib22","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF01955422","article-title":"Calculation of drug-melanin binding energy using molecular modeling","volume":"46","author":"Raghavan","year":"1990","journal-title":"Experientia"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030837","article-title":"Nanocarriers for the delivery of neuroprotective agents in the treatment of ocular neurodegenerative diseases","volume":"15","author":"Patel","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2174\/1389450118666170125144557","article-title":"Cytochrome P450 structure, function and clinical significance: a review","volume":"19","author":"Manikandan","year":"2018","journal-title":"Curr. Drug Targets"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.dmpk.2017.10.002","article-title":"Species differences in drug glucuronidation: humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans","volume":"33","author":"Fujiwara","year":"2018","journal-title":"Drug Metabol. Pharmacokinet."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib26","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1021\/acs.molpharmaceut.0c00260","article-title":"Chitosan\u2013polycaprolactone core\u2013shell microparticles for sustained delivery of bevacizumab","volume":"17","author":"Jiang","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.mtbio.2024.101126_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2019.01.007","article-title":"Long-acting intraocular Delivery strategies for biological therapy of age-related macular degeneration","volume":"296","author":"Iyer","year":"2019","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030269","article-title":"Drug delivery to the posterior segment of the eye: biopharmaceutic and pharmacokinetic considerations","volume":"12","author":"Varela-Fernandez","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib29","article-title":"Considerations for polymers used in ocular drug delivery","volume":"8","author":"Allyn","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.mtbio.2024.101126_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2022.120014","article-title":"Insight on updates in polysaccharides for ocular drug delivery","volume":"297","author":"Chandra","year":"2022","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib31","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s13346-021-00928-3","article-title":"A chitosan-based nanosystem as pneumococcal vaccine delivery platform","volume":"11","author":"Robla","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"11","key":"10.1016\/j.mtbio.2024.101126_bib32","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1211\/0022357022476","article-title":"The potential of chitosan in ocular drug delivery","volume":"55","author":"Alonso","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.mtbio.2024.101126_bib33","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.antiviral.2015.09.013","article-title":"Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries","volume":"123","author":"Dalpiaz","year":"2015","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21020487","article-title":"Chitosan derivatives and their application in biomedicine","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.nano.2008.06.003","article-title":"Ocular nanoparticle toxicity and transfection of the retina and retinal pigment epithelium","volume":"4","author":"Prow","year":"2008","journal-title":"Nanomedicine"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0928-0987(99)00023-8","article-title":"Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits","volume":"9","author":"Giunchedi","year":"1999","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051499","article-title":"Current trends in gelatin-based drug delivery systems","volume":"15","author":"Milano","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib38","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40662-019-0171-0","article-title":"Safety and efficacy outcomes of the Xen45 Gel Stent use for refractory glaucoma: a surgery series from surgeon trainees at a tertiary teaching hospital","volume":"7","author":"Hong","year":"2020","journal-title":"Eye Vis"},{"issue":"9","key":"10.1016\/j.mtbio.2024.101126_bib39","first-page":"814","article-title":"[The dynamic study of retinoic acid and its alginate sodium microspheres in rabbit eye]","volume":"42","author":"Wang","year":"2006","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib40","first-page":"679","article-title":"Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema","volume":"81","author":"Cardillo","year":"2006","journal-title":"Arch. Soc. Esp. Oftalmol."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib41","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1167\/iovs.08-2920","article-title":"A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery","volume":"50","author":"Paganelli","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.mtbio.2024.101126_bib42","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1002\/app.1981.070261124","article-title":"Aliphatic polyesters. I. The degradation of poly(\u03f5\u2010caprolactone)in vivo","volume":"26","author":"Pitt","year":"1981","journal-title":"J. Appl. Polym. Sci."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2024.101126_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08820538.2015.1114865","article-title":"Drug delivery nanoparticles: toxicity comparison in retinal pigment epithelium and retinal vascular endothelial cells","volume":"31","author":"Lin","year":"2016","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.mtbio.2024.101126_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","article-title":"Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology","volume":"211","author":"Andres-Guerrero","year":"2015","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101126_bib45","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874364101206010054","article-title":"Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration","volume":"6","author":"Li","year":"2012","journal-title":"Open Ophthalmol. J."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib46","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ijpharm.2015.10.003","article-title":"Preparation and in vivo evaluation of PCADK\/PLGA microspheres for improving stability and efficacy of rhGH","volume":"495","author":"Wang","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib47","doi-asserted-by":"crossref","first-page":"726","DOI":"10.2174\/1567201812666150316112635","article-title":"Improving protein stability and controlling protein release by adding poly (Cyclohexane-1, 4-diyl acetone dimethylene ketal) to PLGA microspheres","volume":"12","author":"Wang","year":"2015","journal-title":"Curr. Drug Deliv."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib48","doi-asserted-by":"crossref","first-page":"e1516","DOI":"10.1002\/wnan.1516","article-title":"Poly(lactic-co-glycolic acid) devices: production and applications for sustained protein delivery","volume":"10","author":"Lee","year":"2018","journal-title":"Wiley Interdiscip. Rev.-Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.mtbio.2024.101126_bib49","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jconrel.2020.01.023","article-title":"Microencapsulation of luteinizing hormone-releasing hormone agonist in poly (lactic-co-glycolic acid) microspheres by spray-drying","volume":"321","author":"Shi","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101126_bib50","first-page":"39","article-title":"Optimization of experimental parameters for the production of LMWH-loaded polymeric microspheres","volume":"2","author":"Motlekar","year":"2009","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib51","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/10010146","article-title":"Biodegradable polymers for microencapsulation of drugs","volume":"10","author":"Park","year":"2005","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib52","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1039\/C8RA08972H","article-title":"Microfluidic assisted synthesis of PLGA drug delivery systems","volume":"9","author":"Rezvantalab","year":"2019","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib53","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcis.2011.12.078","article-title":"Size-controlled and monodisperse enzyme-encapsulated chitosan microspheres developed by the SPG membrane emulsification technique","volume":"371","author":"Akamatsu","year":"2012","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.mtbio.2024.101126_bib54","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.partic.2021.07.006","article-title":"Fabricating biopolymer-inorganic hybrid microspheres for enzyme immobilization: connect membrane emulsification with biomimetic mineralization","volume":"64","author":"Li","year":"2022","journal-title":"Particuology"},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib55","doi-asserted-by":"crossref","first-page":"636","DOI":"10.3109\/02652048.2012.676092","article-title":"Characterisation and applications of microcapsules obtained by interfacial polycondensation","volume":"29","author":"Zhang","year":"2012","journal-title":"J. Microencapsul."},{"issue":"16","key":"10.1016\/j.mtbio.2024.101126_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168884","article-title":"PLGA\/PLA-Based long-acting injectable depot microspheres in clinical use: production and characterization overview for protein\/peptide delivery","volume":"22","author":"Butreddy","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2024.101126_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.msec.2019.03.009","article-title":"Engineered multifunctional biodegradable hybrid microparticles for paclitaxel delivery in cancer therapy","volume":"102","author":"Dwivedi","year":"2019","journal-title":"Mater. Sci. Eng., C"},{"issue":"11","key":"10.1016\/j.mtbio.2024.101126_bib58","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13111928","article-title":"Pharmaceutical applications of supercritical fluid extraction of emulsions for micro-\/nanoparticle formation","volume":"13","author":"Park","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2020.10.022","article-title":"Post-loading of proangiogenic growth factors in PLGA microspheres","volume":"158","author":"Scheiner","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.mtbio.2024.101126_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.preteyeres.2014.04.002","article-title":"The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies","volume":"42","author":"Herrero-Vanrell","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"issue":"9","key":"10.1016\/j.mtbio.2024.101126_bib61","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1167\/iovs.05-1373","article-title":"Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study","volume":"47","author":"He","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2024.101126_bib62","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2003.12.006","article-title":"Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study","volume":"273","author":"Martinez-Sancho","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib63","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s13346-021-00930-9","article-title":"Co-delivery of glial cell-derived neurotrophic factor (GDNF) and tauroursodeoxycholic acid (TUDCA) from PLGA microspheres: potential combination therapy for retinal diseases","volume":"11","author":"Arranz-Romera","year":"2021","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib64","article-title":"Biodegradable additives modulate ganciclovir release rate from PLGA microspheres destined to intraocular administration","volume":"2","author":"Emilia Barcia","year":"2005","journal-title":"Lett. Drug Des. Discov."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2024.101126_bib65","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ijpharm.2006.07.010","article-title":"Vitamin A palmitate and aciclovir biodegradable microspheres for intraocular sustained release","volume":"326","author":"Martinez-Sancho","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib66","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2011.06.023","article-title":"Retinal ganglion cells survival in a glaucoma model by GDNF\/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure","volume":"156","author":"Checa-Casalengua","year":"2011","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13020228","article-title":"Dexamethasone PLGA microspheres for sub-tenon administration: influence of sterilization and tolerance studies","volume":"13","author":"Barbosa-Alfaro","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib68","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jconrel.2015.05.279","article-title":"Novel biodegradable polyesteramide microspheres for controlled drug delivery in Ophthalmology","volume":"211","author":"Andres-Guerrero","year":"2015","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib69","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.exer.2009.03.012","article-title":"Downregulation of endotoxin-induced uveitis by intravitreal injection of polylactic-glycolic acid (PLGA) microspheres loaded with dexamethasone","volume":"89","author":"Barcia","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mtbio.2024.101126_bib70","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2147\/IJN.S372582","article-title":"Inhalable nano-dimpled microspheres containing budesonide-PLGA for improved aerodynamic performance","volume":"17","author":"Han","year":"2022","journal-title":"Int. J. Nanomed."},{"issue":"10","key":"10.1016\/j.mtbio.2024.101126_bib71","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1023\/A:1026464124412","article-title":"Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process","volume":"17","author":"Herrero-Vanrell","year":"2000","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"sup1","key":"10.1016\/j.mtbio.2024.101126_bib72","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1080\/21691401.2018.1443940","article-title":"Core\/shell PLGA microspheres with controllable in vivo release profile via rational core phase design","volume":"46","author":"Yu","year":"2018","journal-title":"Artif. Cell Nanomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0939-6411(97)00126-4","article-title":"Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride","volume":"45","author":"O'Donnell","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.mtbio.2024.101126_bib74","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3109\/02713683.2010.497599","article-title":"Development of biodegradable controlled release scleral systems of triamcinolone acetonide","volume":"35","author":"Blatsios","year":"2010","journal-title":"Curr. Eye Res."},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2024.101126_bib75","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijpharm.2006.01.043","article-title":"Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin","volume":"312","author":"Anal","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030614","article-title":"Challenges and complications of poly(lactic-co-glycolic acid)-based long-acting drug product development","volume":"14","author":"Lim","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib77","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jconrel.2014.09.003","article-title":"Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications","volume":"193","author":"Ma","year":"2014","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101126_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cis.2015.07.013","article-title":"Structured microparticles with tailored properties produced by membrane emulsification","volume":"225","author":"Vladisavljevic","year":"2015","journal-title":"Adv. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib79","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1080\/10717544.2021.1938756","article-title":"PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application","volume":"28","author":"Su","year":"2021","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib80","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0939-6411(01)00150-3","article-title":"Porous biodegradable microparticles for delivery of pentamidine","volume":"52","author":"Mandal","year":"2001","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.mtbio.2024.101126_bib81","article-title":"Elimination of residual solvent from PLGA microspheres containing risperidone using supercritical carbon dioxide","volume":"57","author":"Kamali","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.mtbio.2024.101126_bib82","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.actbio.2014.04.024","article-title":"Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin","volume":"10","author":"Nan","year":"2014","journal-title":"Acta Biomater."},{"issue":"1\u20133","key":"10.1016\/j.mtbio.2024.101126_bib83","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-3659(98)00076-5","article-title":"Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix","volume":"56","author":"Miyajima","year":"1998","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib84","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0168-3659(99)00149-2","article-title":"Effect of polymer\/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix","volume":"61","author":"Miyajima","year":"1999","journal-title":"J. Contr. Release"},{"issue":"19","key":"10.1016\/j.mtbio.2024.101126_bib85","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevLett.89.195502","article-title":"Coagulation of charged microparticles in neutral gas and charge-induced gel transitions","volume":"89","author":"Ivlev","year":"2002","journal-title":"Phys. Rev. Lett."},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib86","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/03639045.2019.1569025","article-title":"Dual cross-linked chitosan microspheres formulated with spray-drying technique for the sustained release of levofloxacin","volume":"45","author":"Zhou","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib87","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/j.biomaterials.2010.01.031","article-title":"PEG\u2013PLA microparticles for encapsulation and delivery of Tat-EGFP to retinal cells","volume":"31","author":"Rafat","year":"2010","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib88","first-page":"1785","article-title":"Microspheres of biodegradable polymers as a drug-delivery system in the vitreous","volume":"32","author":"Moritera","year":"1991","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib89","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/10717544.2017.1422296","article-title":"Development of a novel morphological paclitaxel-loaded PLGA microspheres for effective cancer therapy: in vitro and in vivo evaluations","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib90","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-3659(99)00255-2","article-title":"First order release rate from porous PLA microspheres with limited exit holes on the exterior surface","volume":"66","author":"Ehtezazi","year":"2000","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.mtbio.2024.101126_bib91","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2016.03.011","article-title":"Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere\/PVA hydrogel composites","volume":"228","author":"Gu","year":"2016","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib92","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2006.02.015","article-title":"Elevated temperature accelerated release testing of PLGA microspheres","volume":"112","author":"Zolnik","year":"2006","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib93","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jconrel.2007.05.034","article-title":"Effect of acidic pH on PLGA microsphere degradation and release","volume":"122","author":"Zolnik","year":"2007","journal-title":"J. Contr. Release"},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib94","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/02652048.2012.742158","article-title":"An overview of preparation and evaluation sustained-release injectable microspheres","volume":"30","author":"Hu","year":"2012","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.mtbio.2024.101126_bib128","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2017.09.029","article-title":"Tolerance of high and low amounts of PLGA microspheres loaded with mineralocorticoid receptor antagonist in retinal target site","volume":"266","author":"Zhao","year":"2017","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib140","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1167\/iovs.05-0531","article-title":"Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage","volume":"47","author":"Amrite","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib138","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1167\/iovs.02-0791","article-title":"Subconjunctival nano- and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression","volume":"44","author":"Kompella","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.mtbio.2024.101126_bib169","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1167\/iovs.16-19300","article-title":"Intravitreal injection of proinsulin-loaded microspheres delays photoreceptor cell death and vision loss in the rd10 mouse model of retinitis pigmentosa","volume":"57","author":"Isiegas","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177998","article-title":"Controlled delivery of tauroursodeoxycholic acid from biodegradable microspheres slows retinal degeneration and vision loss in P23H rats","volume":"12","author":"Fernandez-Sanchez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.mtbio.2024.101126_bib165","first-page":"1002","article-title":"Intravitreous injection of PLGA microspheres encapsulating GDNF promotes the survival of photoreceptors in the rd1\/rd1 mouse","volume":"11","author":"Andrieu-Soler","year":"2005","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib172","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/jop.2006.22.121","article-title":"Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits","volume":"22","author":"He","year":"2006","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib156","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1002\/jbm.a.36995","article-title":"Self-assembling hydrogel loaded with 5-FU PLGA microspheres as a novel vitreous substitute for proliferative vitreoretinopathy","volume":"108","author":"Yu","year":"2020","journal-title":"J. Biomed. Mater. Res., Part A"},{"issue":"11","key":"10.1016\/j.mtbio.2024.101126_bib154","first-page":"3125","article-title":"Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy","volume":"33","author":"Moritera","year":"1992","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.mtbio.2024.101126_bib157","first-page":"2743","article-title":"Sustained delivery of retinoic acid from microspheres of biodegradable polymer in PVR","volume":"34","author":"Giordano","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib107","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0928-0987(97)00023-7","article-title":"Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro\/in vivo evaluation","volume":"5","author":"Conti","year":"1997","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib108","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1081\/PDT-100100542","article-title":"Kinetics of a model nucleoside (guanosine) release from biodegradable poly(DL-lactide-co-glycolide) microspheres: a delivery system for long-term intraocular delivery","volume":"5","author":"Chowdhury","year":"2000","journal-title":"Pharmaceut. Dev. Technol."},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib110","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1089\/jop.2006.132","article-title":"Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis","volume":"23","author":"Duvvuri","year":"2007","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib111","first-page":"665","article-title":"Ganciclovir-loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus","volume":"38","author":"Veloso","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mtbio.2024.101126_bib112","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40199-015-0132-7","article-title":"Improved intraocular bioavailability of ganciclovir by mucoadhesive polymer based ocular microspheres: development and simulation process in Wistar rats","volume":"23","author":"Kapanigowda","year":"2015","journal-title":"Daru"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib102","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1248\/bpb.b16-00437","article-title":"Development of a sustainable release system for a ranibizumab biosimilar using poly(lactic-co-glycolic acid) biodegradable polymer-based microparticles as a platform","volume":"40","author":"Tanetsugu","year":"2017","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib104","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3390\/ph14010050","article-title":"A safe GDNF and GDNF\/BDNF controlled delivery system improves migration in human retinal pigment epithelial cells and survival in retinal ganglion cells: potential usefulness in degenerative retinal pathologies","volume":"14","author":"Arranz-Romera","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib98","doi-asserted-by":"crossref","first-page":"54","DOI":"10.2174\/1874364101206010054","article-title":"Controlled release of bevacizumab through nanospheres for extended treatment of age-related macular degeneration","volume":"6","author":"Li","year":"2012","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.mtbio.2024.101126_bib99","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2019.04.012","article-title":"Highly bioactive, bevacizumab-loaded, sustained-release PLGA\/PCADK microspheres for intravitreal therapy in ocular diseases","volume":"563","author":"Liu","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.mtbio.2024.101126_bib116","doi-asserted-by":"crossref","first-page":"4989","DOI":"10.1167\/iovs.03-0600","article-title":"Periocular injection of microspheres containing PKC412 inhibits choroidal neovascularization in a porcine model","volume":"44","author":"Saishin","year":"2003","journal-title":"Investigative Opthalmology & Visual Science"},{"issue":"11","key":"10.1016\/j.mtbio.2024.101126_bib121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/tvst.9.11.13","article-title":"Treatment efficacy and biocompatibility of a biodegradable aflibercept-loaded microsphere-hydrogel drug delivery system","volume":"9","author":"Liu","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib122","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1167\/tvst.8.1.12","article-title":"Characterization of biodegradable microsphere-hydrogel ocular drug delivery system for controlled and extended release of ranibizumab","volume":"8","author":"Liu","year":"2019","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"10","key":"10.1016\/j.mtbio.2024.101126_bib119","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3390\/pharmaceutics13101548","article-title":"Sustained-release microspheres of Rivoceranib for the treatment of subfoveal choroidal neovascularization","volume":"13","author":"Kim","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib103","first-page":"1783","article-title":"Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma","volume":"13","author":"Jiang","year":"2007","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib150","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2011.06.023","article-title":"Retinal ganglion cells survival in a glaucoma model by GDNF\/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure","volume":"156","author":"Checa-Casalengua","year":"2011","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib149","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jps.20629","article-title":"Neuroprotection of retinal ganglion cells in DBA\/2J mice with GDNF-loaded biodegradable microspheres","volume":"96","author":"Ward","year":"2007","journal-title":"J. Pharmaceut. Sci."},{"issue":"8","key":"10.1016\/j.mtbio.2024.101126_bib146","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/pharmaceutics12080706","article-title":"Fasudil loaded PLGA microspheres as potential intravitreal depot formulation for glaucoma therapy","volume":"12","author":"Mietzner","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mtbio.2024.101126_bib151","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jconrel.2019.01.012","article-title":"Simultaneous co-delivery of neuroprotective drugs from multi-loaded PLGA microspheres for the treatment of glaucoma","volume":"297","author":"Arranz-Romera","year":"2019","journal-title":"J. Contr. Release"},{"issue":"1\u20132","key":"10.1016\/j.mtbio.2024.101126_bib175","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ijpharm.2016.03.026","article-title":"Microencapsulation of rifampicin for the prevention of endophthalmitis: in vitro release studies and antibacterial assessment","volume":"505","author":"Lee","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib176","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1167\/iovs.08-2920","article-title":"A single intraoperative sub-tenon\u2019s capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery","volume":"50","author":"Paganelli","year":"2009","journal-title":"Investigative Opthalmology & Visual Science"},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib179","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.biomaterials.2010.09.063","article-title":"Robust cell integration from co-transplantation of biodegradable MMP2-PLGA microspheres with retinal progenitor cells","volume":"32","author":"Yao","year":"2011","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib132","first-page":"679","article-title":"Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulnes for the treatment of diabetic macular edema","volume":"81","author":"Cardillo","year":"2006","journal-title":"Arch. Soc. Esp. Oftalmol."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib95","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.3390\/ijms23052592","article-title":"Exudative versus nonexudative age-related macular degeneration: physiopathology and treatment options","volume":"23","author":"Fernandes","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2024.101126_bib96","first-page":"5397","article-title":"Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis","volume":"9","author":"Ba","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib97","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.ophtha.2005.02.007","article-title":"Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration twelve-week results of an uncontrolled open-label clinical study","volume":"112","author":"Michels","year":"2005","journal-title":"Ophthalmology"},{"issue":"20","key":"10.1016\/j.mtbio.2024.101126_bib100","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1102673","article-title":"Ranibizumab and bevacizumab for neovascular age-related macular degeneration","volume":"364","author":"Martin","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib101","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2007.09.012","article-title":"Pharmacokinetics of intravitreal ranibizumab (Lucentis)","volume":"114","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib105","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ophtha.2016.11.007","article-title":"Diagnosis and treatment of acute retinal necrosis: a report by the American academy of ophthalmology","volume":"124","author":"Schoenberger","year":"2017","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib106","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/cid\/cix683","article-title":"Acute retinal necrosis caused by the zoster vaccine virus","volume":"65","author":"Heath","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib109","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/jop.2016.0140","article-title":"Cytomegalovirus retinitis: a review","volume":"33","author":"Port","year":"2017","journal-title":"J. Ocul. Pharmacol. Therapeut."},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib113","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s004170050360","article-title":"Natural history of choroidal neovascularization induced by vascular endothelial growth factor in the primate","volume":"238","author":"Cui","year":"2000","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"8","key":"10.1016\/j.mtbio.2024.101126_bib114","first-page":"3178","article-title":"Growth factor localization in choroidal neovascular membranes of age-related macular degeneration","volume":"35","author":"Amin","year":"1994","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.mtbio.2024.101126_bib115","first-page":"3158","article-title":"VEGF is major stimulator in model of choroidal neovascularization","volume":"41","author":"Kwak","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.mtbio.2024.101126_bib117","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.2147\/IJN.S135133","article-title":"Apatinib-loaded nanoparticles suppress vascular endothelial growth factor-induced angiogenesis and experimental corneal neovascularization","volume":"12","author":"Lee","year":"2017","journal-title":"Int. J. Nanomed."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib118","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.mtbio.2024.101126_bib120","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1080\/02713683.2017.1302590","article-title":"In vivo efficacy of an injectable microsphere-hydrogel ocular drug delivery system","volume":"42","author":"Osswald","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"10","key":"10.1016\/j.mtbio.2024.101126_bib123","first-page":"1905","article-title":"Acute central serous chorioretinopathy: factors influencing episode duration","volume":"37","author":"Daruich","year":"2017","journal-title":"retin.-J. Retin. Vitr. Dis."},{"key":"10.1016\/j.mtbio.2024.101126_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.07.003","article-title":"Central serous chorioretinopathy: towards an evidence-based treatment guideline","volume":"73","author":"van Rijssen","year":"2019","journal-title":"Prog. Retin. Eye Res."},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/ceo.14201","article-title":"Central serous chorioretinopathy: a review","volume":"51","author":"Fung","year":"2023","journal-title":"Clin. Exp. Ophthalmol."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib126","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib127","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.5.2.2","article-title":"Oral mineralocorticoid-receptor antagonists: real-life experience in clinical subtypes of nonresolving central serous chorioretinopathy with chronic epitheliopathy","volume":"5","author":"Daruich","year":"2016","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib129","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/09286586.2016.1193618","article-title":"Ten emerging trends in the epidemiology of diabetic retinopathy","volume":"23","author":"Sabanayagam","year":"2016","journal-title":"Ophthalmic Epidemiol."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib130","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/jdi.12929","article-title":"Clinical preferences and trends of anti-vascular endothelial growth factor treatments for diabetic macular edema in Japan","volume":"10","author":"Sugimoto","year":"2019","journal-title":"J. Diabetes Investig"},{"issue":"9","key":"10.1016\/j.mtbio.2024.101126_bib131","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.ophtha.2005.03.023","article-title":"Comparison of intravitreal versus posterior sub\u2013tenon\u2019s capsule injection of triamcinolone acetonide for diffuse diabetic macular edema","volume":"112","author":"Cardillo","year":"2005","journal-title":"Ophthalmology"},{"issue":"14","key":"10.1016\/j.mtbio.2024.101126_bib133","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93751","article-title":"Diabetic retinopathy: current understanding, mechanisms, and treatment strategies","volume":"2","author":"Duh","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.mtbio.2024.101126_bib134","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40662-015-0026-2","article-title":"Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss","volume":"2","author":"Lee","year":"2015","journal-title":"Eye Vis"},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib135","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12071466","article-title":"Aldehyde dehydrogenase and aldo-keto reductase enzymes: basic concepts and emerging roles in diabetic retinopathy","volume":"12","author":"Karan","year":"2023","journal-title":"Antioxidants"},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084357","article-title":"Requirement of NOX2 expression in both retina and bone marrow for diabetes-induced retinal vascular injury","volume":"8","author":"Rojas","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib137","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(01)01192-X","article-title":"Budesonide reduces vascular endothelial growth factor secretion and expression in airway (Calu-1) and alveolar (A549) epithelial cells","volume":"425","author":"Bandi","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib139","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/jcp.10238","article-title":"Inhibition of protein kinase C decreases prostaglandin-induced breakdown of the blood-retinal barrier","volume":"195","author":"Saishin","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0301-4738.73682","article-title":"Natural history of glaucoma","volume":"59","author":"Pan","year":"2011","journal-title":"Indian J. Ophthalmol."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib142","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/ajhp\/62.7.691","article-title":"Glaucoma and its treatment: a review","volume":"62","author":"Lee","year":"2005","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib143","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11050888","article-title":"Ocular hypertension results in hypoxia within glia and neurons throughout the visual projection","volume":"11","author":"Jassim","year":"2022","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib144","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/02652040802141039","article-title":"Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W\/O\/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics","volume":"26","author":"Karatas","year":"2009","journal-title":"J. Microencapsul."},{"issue":"11","key":"10.1016\/j.mtbio.2024.101126_bib145","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","volume":"125","author":"Tanna","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.mtbio.2024.101126_bib147","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1167\/iovs.17-23276","article-title":"Topical ripasudil suppresses retinal ganglion cell death in a mouse model of normal tension glaucoma","volume":"59","author":"Akaiwa","year":"2018","journal-title":"Investigative Opthalmology & Visual Science"},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib148","first-page":"585","article-title":"Neuroprotection and regeneration in glaucoma","volume":"18","author":"Levin","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"issue":"1","key":"10.1016\/j.mtbio.2024.101126_bib152","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review","volume":"59","author":"Idrees","year":"2019","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.mtbio.2024.101126_bib153","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ejpb.2018.06.013","article-title":"Experimental proliferative vitreoretinopathy in rabbits by delivery of bioactive proteins with gelatin microspheres","volume":"129","author":"Hirose","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0161-6420(84)34318-4","article-title":"5-fluorouracil: new applications in complicated retinal detachment for an established antimetabolite","volume":"91","author":"Blumenkranz","year":"1984","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.mtbio.2024.101126_bib158","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ajo.2008.05.002","article-title":"Effect of oral 13-cis-retinoic acid treatment on postoperative clinical outcome of eyes with proliferative vitreoretinopathy","volume":"146","author":"Chang","year":"2008","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.mtbio.2024.101126_bib159","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.biopha.2017.10.109","article-title":"Retinoic acid-loaded alginate microspheres as a slow release drug delivery carrier for intravitreal treatment","volume":"97","author":"Wang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mtbio.2024.101126_bib160","first-page":"40","volume":"1","author":"Hamel","year":"2006","journal-title":"Rare Dis."},{"key":"10.1016\/j.mtbio.2024.101126_bib161","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","article-title":"Non-syndromic retinitis pigmentosa","volume":"66","author":"Verbakel","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"issue":"6586","key":"10.1016\/j.mtbio.2024.101126_bib162","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/382080a0","article-title":"Characterization of a multicomponent receptor for GDNF","volume":"382","author":"Treanor","year":"1996","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.mtbio.2024.101126_bib163","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1097\/00001756-199711100-00005","article-title":"In vivo neurotrophic effects of GDNF on axotomized retinal ganglion cells","volume":"8","author":"Klocker","year":"1997","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib164","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1006\/mthe.2001.0498","article-title":"Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa","volume":"4","author":"McGee","year":"2001","journal-title":"Mol. Ther."},{"issue":"8","key":"10.1016\/j.mtbio.2024.101126_bib166","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1167\/iovs.11-7496","article-title":"Tauroursodeoxycholic acid prevents retinal degeneration in transgenic P23H rats","volume":"52","author":"Fernandez-Sanchez","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.mtbio.2024.101126_bib168","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1089\/hum.2012.067","article-title":"Proinsulin slows retinal degeneration and vision loss in the P23H rat model of retinitis pigmentosa","volume":"23","author":"Fernandez-Sanchez","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mtbio.2024.101126_bib170","first-page":"m4979","article-title":"Uveitis for the non-ophthalmologist","volume":"372","author":"Burkholder","year":"2021","journal-title":"BMJ Br. Med. J. (Clin. Res. Ed.)"},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib171","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","article-title":"Understanding uveitis: the impact of research on visual outcomes","volume":"30","author":"de Smet","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.mtbio.2024.101126_bib173","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-023-01112-3","article-title":"Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases","author":"Bao","year":"2023","journal-title":"Nat. Biomed. Eng."},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib174","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0008-4182(00)80124-6","article-title":"Effect of prophylactic antibiotics and incision type on the incidence of endophthalmitis after cataract surgery","volume":"35","author":"Colleaux","year":"2000","journal-title":"Can. J. Ophthalmol."},{"issue":"2","key":"10.1016\/j.mtbio.2024.101126_bib177","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jcrs.2016.12.015","article-title":"Intraindividual comparison of capsule behavior of 2 hydrophobic acrylic intraocular lenses during a 5-year follow-up","volume":"43","author":"Kahraman","year":"2017","journal-title":"J. Cataract Refract. Surg."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib178","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1080\/02713683.2018.1437455","article-title":"Poly(lactic-co-glycolic) acid as a slow-release drug-carrying matrix for methotrexate coated onto intraocular lenses to conquer posterior capsule opacification","volume":"43","author":"Kassumeh","year":"2018","journal-title":"Curr. Eye Res."},{"issue":"9","key":"10.1016\/j.mtbio.2024.101126_bib180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/02713689508995797","article-title":"Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres","volume":"14","author":"Giordano","year":"1995","journal-title":"Curr. Eye Res."},{"issue":"10","key":"10.1016\/j.mtbio.2024.101126_bib181","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1167\/iovs.16-21334","article-title":"Evaluation of the toxicity of intravitreally injected PLGA microspheres and rods in monkeys and rabbits: effects of depot size on inflammatory response","volume":"58","author":"Thackaberry","year":"2017","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"4","key":"10.1016\/j.mtbio.2024.101126_bib182","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3109\/10611869409015909","article-title":"Polysulfone capillary fiber for intraocular drug delivery: in vitro and in vivo evaluations","volume":"2","author":"Rahimy","year":"1994","journal-title":"J. Drug Target."},{"issue":"6","key":"10.1016\/j.mtbio.2024.101126_bib183","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1018822002353","article-title":"pH and osmotic pressure inside biodegradable microspheres during erosion","volume":"16","author":"Brunner","year":"1999","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"7","key":"10.1016\/j.mtbio.2024.101126_bib184","article-title":"Near\u2010infrared\u2010triggered on\u2010demand controlled release of adeno\u2010associated virus from alginate hydrogel microbeads with heat transducer for gene therapy","volume":"19","author":"Takatsuka","year":"2023","journal-title":"Small"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006424001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:54:31Z","timestamp":1762034071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006424001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":184,"alternative-id":["S2590006424001856"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101126","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2024.101126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101126"}}